Return to Listing

2 result(s) for

PI Name Protocol # Title
Raymond Bergan STUDY00015588 Serial Measurements of Molecular and Architectural Responses to Therapy
Michael Heinrich STUDY00019801 [NCI CIRB] - S1712 - A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination with BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients with Molecular Evidence of Disease
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080